TOMAC: Bioinspired Flow Generation in Tubeless Organ-on-a-chip using Magnetic Artificial Cilia

The TOMAC project develops a Magnetic Artificial Cilia pump for Organ-on-a-Chip systems, enabling automated, physiological fluid flow to improve drug testing accuracy and industry adoption.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

Currently, 90% of the drugs fail to pass clinical trials. One of the key reasons is that the animal models used in the preclinical phase poorly predict the human response to the drugs. Organ-on-a-Chip (OoC) is a game-changing technology as one of the alternative methodologies to animal models.

Organ-on-a-Chip Technology

The heart of an OoC system is an ‘Organ-chip’: cm-sized devices with micro-channels and chambers in which human cells can be grown to closely mimic human tissues. More and more evidence shows that OoCs are more representative models than animals.

Industry Adoption Challenges

However, the industry adoption of OoCs is still very limited. OoC users and developers simply have to choose between:

  1. OoCs with physiologically relevant flow but not fit for standard operating procedures in the pharmaceutical industry.
  2. OoCs that are compatible but less physiological because of the absence or inadequacy of the flow.

TOMAC Project Solution

The TOMAC project offers a novel solution called “Magnetic Artificial Cilia (MAC) pump”: a chip-sized modular and tubeless flow system that, on one hand, eliminates manual handling and enables automation, and on the other hand provides physiological flow for a range of organ models.

Technology Behind MAC

The technology behind MAC is based on micrometer-sized magnetic hair-like structures called Magnetic Artificial Cilia (MAC), which are inspired by cilia occurring in nature. The MAC are flexible micro-actuators that respond to a varying magnetic field (created by the actuation system) by rotating or oscillating, and thus create a controlled fluid flow.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-4-2024
Einddatum30-9-2025
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • TECHNISCHE UNIVERSITEIT EINDHOVENpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000

Vergelijkbare projecten uit andere regelingen

ERC STG

Evolving Organs-on-Chip from developmental engineering to “mechanical re-evolution”

EvOoC develops smart Organs-on-Chip platforms that utilize mechanical forces and machine learning to enhance tissue regeneration and disease modeling for innovative therapeutic solutions.

€ 2.430.625
MIT Haalbaarheid

PRECISION

Dit project onderzoekt het gebruik van 3D-printing om de beperkingen van fotolithografie bij de productie van organ-on-chip modellen te overwinnen voor geneesmiddelentests en biologieonderzoek.

€ 20.000
MIT Haalbaarheid

multisampLOC systeem

Celnext en IMcoMET ontwikkelen een toegankelijk multisampLOC-systeem voor farmacologisch en biomedisch onderzoek, gericht op het verbeteren van de bemonsteling en throughput van 3D lever-modellen.

€ 20.000
MIT Haalbaarheid

AdDitive mAnufacturing Microfluidica – ADAM

PimBio B.V. ontwikkelt kosteneffectieve, klantspecifieke microfluïdische chips voor biotechnologie en gezondheidszorg om onderzoek te versnellen.

€ 20.000